株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

便秘症:世界の治験動向

Constipation Global Clinical Trials Review, H2, 2016

発行 GlobalData 商品コード 235279
出版日 ページ情報 英文 337 Pages
即納可能
価格
本日の銀行送金レート: 1USD=116.15円で換算しております。
Back to Top
便秘症:世界の治験動向 Constipation Global Clinical Trials Review, H2, 2016
出版日: 2016年11月30日 ページ情報: 英文 337 Pages
概要

当レポートでは、便秘症に関する臨床研究の最新動向について分析しており、地域別の治験件数、治験の段階別進行状況、被験者採用の状況、有望なスポンサー、各企業や研究機関における研究の進行状況、有望な薬剤の比較といった情報をまとめています。

イントロダクション

  • 便秘症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要5カ国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:胃腸疾患治療薬の治験における便秘症の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:胃腸疾患治療薬の治験における便秘症の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

便秘症治療薬の治験に携わっている主要企業

有望な薬剤

最新の治験ニュース

治験のプロファイル

  • 主要企業の治験の概要
    • Shire Plc
    • 武田薬品工業
    • Novartis AG
    • Sucampo Pharmaceuticals, Inc.
    • Ironwood Pharmaceuticals, Inc.
    • Valeant Pharmaceuticals International, Inc.
    • Actavis plc
    • Meda AB
    • Pawfect Foods Inc.
    • AstraZeneca PLC
  • 代表的な研究機関・病院の治験の概要
    • Mayo Clinic
    • Academic Medical Center
    • Cedars-Sinai Medical Center
    • Department of Health, UK
    • Federal University of Sao Paulo
    • Guang'anmen Hospital, China Academy of Chinese Medical Sciences
    • Hong Kong Baptist University
    • Massachusetts General Hospital
    • Tehran University of Medical Sciences
    • Tongji Hospital

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC3945CTIDB

GlobalData's clinical trial report, "Constipation Global Clinical Trials Review, H2, 2016" provides an overview of Constipation clinical trials scenario. This report provides top line data relating to the clinical trials on Constipation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Constipation to Gastrointestinal Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Constipation to Gastrointestinal Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Constipation Therapeutics Clinical Trials 27
  • Prominent Drugs 29
  • Latest Clinical Trials News on Constipation 30
  • Oct 19, 2016: Ardelyx Announces the Presentation of Positive Global Endpoint Findings from Phase 2b Trial of Tenapanor in Patients with IBS-C at ACG Annual Meeting 30
  • Oct 17, 2016: Synergy Pharmaceuticals Presents Long-Term Data for Plecanatide in Chronic Idiopathic Constipation at the American College of Gastroenterology Annual Scientific Meeting 30
  • Oct 03, 2016: Albireo Announces Positive Top-Line Phase 3 Results for Elobixibat in Japan 31
  • Sep 30, 2016: EA Pharma and Mochida Pharmaceutical Announce the Results of Phase 3 Study of AJG533 for Chronic Constipation Conducted in Japan 32
  • Sep 28, 2016: Synergy Pharmaceuticals Announces New Plecanatide Data Presentations at Upcoming Scientific Meeting and Provides Update on IBS-C Program 32
  • Clinical Trial Profile Snapshots 34

Appendix 334

  • Abbreviations 334
  • Definitions 334
  • Research Methodology 335
  • Secondary Research 335
  • About GlobalData 336
  • Contact Us 336
  • Disclaimer 336
  • Source 337

List of Tables

List of Tables

  • Constipation Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Constipation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Constipation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Constipation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
  • Constipation Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
  • Constipation Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
  • Constipation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
  • Constipation Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
  • Proportion of Constipation to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 14
  • Constipation Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Constipation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Constipation to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 17
  • Constipation Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Constipation Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Constipation Therapeutics, Global, Clinical Trials by Phase, 2016* 20
  • Constipation Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
  • Constipation Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Constipation Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Constipation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Constipation Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
  • Constipation Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Constipation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
  • Constipation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List of Figures

List of Figures

  • Constipation Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Constipation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Constipation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Constipation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
  • Constipation Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
  • Constipation Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
  • Constipation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
  • Constipation Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 13
  • Proportion of Constipation to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 14
  • Constipation Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Constipation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Constipation to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 17
  • Constipation Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Constipation Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Constipation Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
  • Constipation Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
  • Constipation Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Constipation Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Constipation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Constipation Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
  • Constipation Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Constipation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
  • Constipation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
  • GlobalData Methodology 335
Back to Top